scholarly journals Purificación, clonación y expresión de inhibidores peptídicos de proteasas de potencial aplicación biomédica a partir de Solanum tuberosum spp.

2017 ◽  
Author(s):  
◽  
Mariana Edith Tellechea

Los inhibidores de proteasas de naturaleza proteica son importantes moléculas reguladoras que inhiben la acción de enzimas proteolíticas y se encuentran extensamente distribuidos en diferentes tejidos de animales, plantas y microorganismos. En su gran mayoría, los inhibidores de proteasas presentes en la naturaleza son proteicos, con la excepción de pequeños inhibidores de microorganismos. Estas moléculas han demostrado su acción en el tratamiento de diferentes patologías en las cuales la desregulación en la acción de las proteasas puede conducir a desequilibrios fisiológicos que llevan a la muerte celular. El presente trabajo de tesis doctoral tiene como objetivo el estudio de nuevas miniproteínas inhibidoras de carboxipeptidasas de tipo “cystine knot” a partir de extractos de tubérculos de Solanum tuberosum grupo andígenum variedada Churqueña. Para este propósito se aplicaron una diversidad de técnicas tales como la espectrometría de masas, biología molecular, expresión recombinante de proteínas, ensayos enzimáticos y caracterización del plegamiento oxidativo. Dentro de estas técnicas, la espectrometría de masas ha sido de gran importancia en este trabajo la cual fue de utilidad en la identificación, caracterización y validación de las moléculas estudiadas. El trabajo se encuentra dividido en tres capítulos a través de los cuales se presentan los resultados obtenidos. En el primer capítulo se describe el estudio y caracterización de un extracto crudo de tubérculos de papa andina determinando su actividad inhibitoria frente a proteasas de diferente tipo mecanístico. Se estudió la estabilidad térmica de los inhibidores de carboxipeptidasas presentes en el extracto y se determinaron los pesos moleculares de las proteínas resistentes a este tratamiento térmico mediante espectrometría de masas MALDI-TOF. Además, se utilizó una técnica proteómica, denominada Intensity Fading MALDI-TOF, mediante la cual se verificó la interacción de moléculas presentes en el extracto con carboxipeptidasa A. Por último, se purificó una molécula que produce inhibición de carboxipeptidasa A mediante cromatografía de afinidad y se realizó un análisis de la huella peptídica o PMF (Peptide Mass Fingerprinting) para su identificación de su secuencia primaria en bases de datos. En el segundo capítulo se presenta el estudio de dos miniproteínas con potencial actividad inhibitoria de carboxipeptidasas. Para llevarlo a cabo, ambas proteínas se expresaron de forma recombinante, se determinó su actividad inhibitoria y se realizaron estudios de plegamiento oxidativo. Además se presentan en este capítulo, modelos estructurales de una de las miniproteínas expresadas utilizando herramientas bioinformáticas. En el tercer capítulo, se aisló desde un brote de tubérculo de Churqueña el ARNm de un tercer inhibidor de carboxipeptidasa. En este capítulo, se muestran los resultados de la expresión recombinante y purificación de este inhibidor, y se presenta su actividad inhibitoria frente a carboxipeptidasas A y B. Asimismo, se describe la identificación de la proteína nativa en el extracto de papa mediante técnicas proteómicas como PMF-MALDI-TOF MS y secuenciación de novo PMF-MALDI-TOF-TOF/MS/MS.

2015 ◽  
Vol 53 (8) ◽  
pp. 2480-2485 ◽  
Author(s):  
Huixia Chui ◽  
Michael Chan ◽  
Drexler Hernandez ◽  
Patrick Chong ◽  
Stuart McCorrister ◽  
...  

Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has gained popularity in recent years for rapid bacterial identification, mostly at the genus or species level. In this study, a rapid method to identify the Escherichia coli flagellar antigen (H antigen) at the subspecies level was developed using a MALDI-TOF MS platform with high specificity and sensitivity. Flagella were trapped on a filter membrane, and on-filter trypsin digestion was performed. The tryptic digests of each flagellin then were collected and analyzed by MALDI-TOF MS through peptide mass fingerprinting. Sixty-one reference strains containing all 53 H types and 85 clinical strains were tested and compared to serotyping designations. Whole-genome sequencing was used to resolve conflicting results between the two methods. It was found that DHB (2,5-dihydroxybenzoic acid) worked better than CHCA (α-cyano-4-hydroxycinnamic acid) as the matrix for MALDI-TOF MS, with higher confidence during protein identification. After method optimization, reference strains representing all 53 E. coli H types were identified correctly by MALDI-TOF MS. A custom E. coli flagellar/H antigen database was crucial for clearly identifying the E. coli H antigens. Of 85 clinical isolates tested by MALDI-TOF MS-H, 75 identified MS-H types (88.2%) matched results obtained from traditional serotyping. Among 10 isolates where the results of MALDI-TOF MS-H and serotyping did not agree, 60% of H types characterized by whole-genome sequencing agreed with those identified by MALDI-TOF MS-H, compared to only 20% by serotyping. This MALDI-TOF MS-H platform can be used for rapid and cost-effective E. coli H antigen identification, especially during E. coli outbreaks.


The Analyst ◽  
2015 ◽  
Vol 140 (5) ◽  
pp. 1717-1730 ◽  
Author(s):  
Pablo J. Villacorta ◽  
Antonio Salmerón-García ◽  
David A. Pelta ◽  
José Cabeza ◽  
Antonio Lario ◽  
...  

A cluster-based comparison algorithm applied to the MALDI-TOF-MS peptide mass fingerprint allows for tracking major changes in protein such as monoclonal antibodies.


2007 ◽  
Vol 27 (1) ◽  
pp. 7-12 ◽  
Author(s):  
M. Shabab ◽  
Mahesh J. Kulkarni ◽  
M. Islam Khan

Antibodies ◽  
2020 ◽  
Vol 9 (2) ◽  
pp. 8 ◽  
Author(s):  
Georg Tscheuschner ◽  
Timm Schwaar ◽  
Michael G. Weller

Thousands of antibodies for diagnostic and other analytical purposes are on the market. However, it is often difficult to identify duplicates, reagent changes, and to assign the correct original publications to an antibody. This slows down scientific progress and might even be a cause of irreproducible research and a waste of resources. Recently, activities were started to suggest the sole use of recombinant antibodies in combination with the open communication of their sequence. In this case, such uncertainties should be eliminated. Unfortunately, this approach seems to be rather a long-term vision since the development and manufacturing of recombinant antibodies remain quite expensive in the foreseeable future. Nearly all commercial antibody suppliers also may be reluctant to publish the sequence of their antibodies, since they fear counterfeiting. De novo sequencing of antibodies is also not feasible today for a reagent user without access to the hybridoma clone. Nevertheless, it seems to be crucial for any scientist to have the opportunity to identify an antibody undoubtedly to guarantee the traceability of any research activity using antibodies from a third party as a tool. For this purpose, we developed a method for the identification of antibodies based on a MALDI-TOF MS fingerprint. To circumvent lengthy denaturation, reduction, alkylation, and enzymatic digestion steps, the fragmentation was performed with a simple formic acid hydrolysis step. Eighty-nine unknown monoclonal antibodies were used for this study to examine the feasibility of this approach. Although the molecular assignment of peaks was rarely possible, antibodies could be easily recognized in a blinded test, simply from their mass-spectral fingerprint. A general protocol is given, which could be used without any optimization to generate fingerprints for a database. We want to propose that, in most scientific projects relying critically on antibody reagents, such a fingerprint should be established to prove and document the identity of the used antibodies, as well as to assign a specific reagent to a datasheet of a commercial supplier, public database record, or antibody ID.


2004 ◽  
Vol 3 (2) ◽  
pp. 23-30 ◽  
Author(s):  
Óscar Yanes ◽  
Josep Villanueva ◽  
Enrique Querol ◽  
Francesc X. Aviles

PLoS ONE ◽  
2021 ◽  
Vol 16 (8) ◽  
pp. e0255611
Author(s):  
Nattapon Riengvirodkij ◽  
Sittiruk Roytrakul ◽  
Janthima Jaresitthikunchai ◽  
Narumon Phaonakrop ◽  
Sawanya Charoenlappanich ◽  
...  

Mitral valve disease (MVD) is an important and most frequently acquired heart disease found in dogs. MVD is classified into different stages according to its severity. There is a challenge in differentiation between asymptomatic and symptomatic stages of the MVD. Moreover, pulmonary hypertension (PH) is a common complication in dogs affected by MVD. In clinical practice, there are also some limitations to identify PH. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is a technique that can characterize specific patterns of peptide mass called peptide barcodes from various samples. Besides, in combination with liquid chromatography-tandem mass spectrometry (LC-MS/MS), potential peptide sequences associated with specific conditions could be identified. The present study aimed to use MALDI-TOF coupled with LC-MS/MS to characterize specific peptide barcodes and potential peptide candidates in serum samples from healthy dogs, dogs with MVD stage B (MVD B, asymptomatic stage), MVD stage C (MVD C, symptomatic stage), MVD stage B with PH (MVD B PH), and MVD stage C with PH (MVD C PH). Discrete clusters of the 5 sample groups were identified by 3D plot analysis. Peptide barcodes also revealed differences in peptide patterns among the 5 groups. Six amino acid sequences of peptide candidates at 1,225.60, 1,363.85, 1,688.71, 1789.52, 2020.21, and 2156.42 Da were identified as part of the proteins CLCN1, CLUL1, EDNRA, PTEN, SLC39A7, and CLN6, respectively. The network interactions between these discovered proteins and common cardiovascular drugs were also investigated. These results demonstrate that MALDI-TOF MS has promise as an optional technique for diagnosing dogs affected by asymptomatic and symptomatic stages of MVD with and without PH. Further studies are required to identify peptide barcodes in dogs with other diseases to create peptide barcode databases in veterinary medicine before using this method as a novel diagnostic tool in the future.


Sign in / Sign up

Export Citation Format

Share Document